Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production

Clinical Immunology

Volumn 136, Issue 1, 2010, Pages 130-138

  Liao, Anne P ^a,b   Salajegheh, Mohammad ^a,b   Morehouse, Chris ^c   Nazareno, Remedios ^a,b   Jubin, Ronald G ^d   Jallal, Bahija ^c   Yao, Yihong ^c   Greenberg, Steven A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c MEDIMMUNE   (United States)

^d PBL InterferonSource   (United States)

Author keywords

Myositis; Plasmacytoid dendritic cells; Systemic lupus erythematosus; Type 1 interferons

Indexed keywords

ALPHA INTERFERON; ALPHA2A INTERFERON; BETA INTERFERON; INTERFERON RECEPTOR; TOLL LIKE RECEPTOR 9;

ARTICLE; AUTOCRINE EFFECT; AUTOIMMUNE DISEASE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; AUTOCRINE COMMUNICATION; CARRIER PROTEINS; CELL COUNT; CYTOKINES; DENDRITIC CELLS; ENDOPEPTIDASES; GENE EXPRESSION; GTP-BINDING PROTEINS; HUMANS; INTERFERON ALFA-2A; INTERFERON TYPE I; INTERFERON-ALPHA; INTERFERON-BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; LEUKOCYTES, MONONUCLEAR; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN ISOFORMS; PROTEINS; RECEPTOR, INTERFERON ALPHA-BETA; TOLL-LIKE RECEPTOR 9; TRANSCRIPTION, GENETIC; UBIQUITINS;

EID: 77953025081     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.02.014     Document Type: Article

References (42)

1. Pascual V., Farkas L., and Banchereau J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr. Opin. Immunol. 18 (2006) 676-682
2. Crow M.K. Type I interferon in systemic lupus erythematosus. Curr. Top. Microbiol. Immunol. 316 (2007) 359-386
3. Ronnblom L., Alm G.V., and Eloranta M.L. Type I interferon and lupus. Curr. Opin. Rheumatol. 21 (2009) 471-477
4. Greenberg S.A. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 69 (2007) 2008-2019
5. Greenberg S.A. Inflammatory myopathies: disease mechanisms. Curr. Opin. Neurol. 22 (2009) 516-523
6. A phase 2A, multicenter, randomized, double-blind, placebo-controlled, parallel-dose study to evaluate the safety and tolerability of multiple subcutaneous doses of MEDI-545, a fully human anti-interferon-alpha monoclonal antibody, in subjects with systemic lupus erythematosus. http://clinicaltrials.gov/ct2/show/NCT00657189.
7. A phase I, randomized, placebo-controlled, double-blind, dose-escalation study of single and repeat doses of rhuMAb IFNalpha, administered through the SC or IV route, in adults with systemic lupus erythematosus. http://clinicaltrials.gov/ct2/show/NCT00541749.
8. A phase 1b, randomized, double-blind, placebo-controlled, multicenter study to evaluate safety of multiple-dose, intravenously administered MEDI-545, a fully human anti Interferon-alpha monoclonal antibody, in adult patients with dermatomyositis or polymyositis. http://clinicaltrials.gov/ct2/show/NCT00533091.
9. Greenberg S.A., Pinkus J.L., Pinkus G.S., Burleson T., Sanoudou D., Tawil R., Barohn R.J., Saperstein D.S., Briemberg H.R., Ericsson M., Park P., and Amato A.A. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann. Neurol. 57 (2005) 664-678
10. Lopez de Padilla C.M., Vallejo A.N., McNallan K.T., Vehe R., Smith S.A., Dietz A.B., Vuk-Pavlovic S., and Reed A.M. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum. 56 (2007) 1658-1668
11. Wenzel J., Schmidt R., Proelss J., Zahn S., Bieber T., and Tuting T. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin. Exp. Dermatol. 31 (2006) 576-582
12. McNiff J.M., and Kaplan D.H. Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus. J. Cutan. Pathol. 35 (2008) 452-456
13. Tucci M., Quatraro C., Lombardi L., Pellegrino C., Dammacco F., and Silvestris F. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum. 58 (2008) 251-262
14. Farkas L., Beiske K., Lund-Johansen F., Brandtzaeg P., and Jahnsen F.L. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159 (2001) 237-243
15. Vermi W., Lonardi S., Morassi M., Rossini C., Tardanico R., Venturini M., Sala R., Tincani A., Poliani P.L., Calzavara-Pinton P.G., Cerroni L., Santoro A., and Facchetti F. Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage. Immunobiology 214 (2009) 877-886
16. Walsh R.J., Kong S.W., Yao Y., Jallal B., Kiener P.A., Pinkus J.L., Beggs A.H., Amato A.A., and Greenberg S.A. Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum. 56 (2007) 3784-3792
17. Isaacs A., and Burke D.C. Mode of action of interferon. Nature 182 (1958) 1073-1074
18. Friedman R.M. Effect of interferon treatment on interferon production. J. Immunol. 96 (1966) 872-877
19. Stewart II W.E., Gosser L.B., and Lockart Jr. R.Z. Priming: a nonantiviral function of interferon. J. Virol. 7 (1971) 792-801
20. Harada H., Matsumoto M., Sato M., Kashiwazaki Y., Kimura T., Kitagawa M., Yokochi T., Tan R.S., Takasugi T., Kadokawa Y., Schindler C., Schreiber R.D., Noguchi S., and Taniguchi T. Regulation of IFN-alpha/beta genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-alpha/beta. Genes Cells 1 (1996) 995-1005
21. Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., and Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett. 441 (1998) 106-110
22. Hata N., Sato M., Takaoka A., Asagiri M., Tanaka N., and Taniguchi T. Constitutive IFN-alpha/beta signal for efficient IFN-alpha/beta gene induction by virus. Biochem. Biophys. Res. Commun. 285 (2001) 518-525
23. Takauji R., Iho S., Takatsuka H., Yamamoto S., Takahashi T., Kitagawa H., Iwasaki H., Iida R., Yokochi T., and Matsuki T. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J. Leukoc. Biol. 72 (2002) 1011-1019
24. Kerkmann M., Rothenfusser S., Hornung V., Towarowski A., Wagner M., Sarris A., Giese T., Endres S., and Hartmann G. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170 (2003) 4465-4474
25. Sato M., Tanaka N., Hata N., Oda E., and Taniguchi T. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett. 425 (1998) 112-116
26. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., Nakaya T., Katsuki M., Noguchi S., Tanaka N., and Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13 (2000) 539-548
27. Marie I., Durbin J.E., and Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. Embo J. 17 (1998) 6660-6669
28. Yoneyama M., Suhara W., Fukuhara Y., Sato M., Ozato K., and Fujita T. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. 120 (1996) 160-169
29. Ito T., Kanzler H., Duramad O., Cao W., and Liu Y.J. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107 (2006) 2423-2431
30. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., Giese T., Engelmann H., Endres S., Krieg A.M., and Hartmann G. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31 (2001) 3026-3037
31. Gibson S.J., Lindh J.M., Riter T.R., Gleason R.M., Rogers L.M., Fuller A.E., Oesterich J.L., Gorden K.B., Qiu X., McKane S.W., Noelle R.J., Miller R.L., Kedl R.M., Fitzgerald-Bocarsly P., Tomai M.A., and Vasilakos J.P. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell. Immunol. 218 (2002) 74-86
32. Osawa Y., Iho S., Takauji R., Takatsuka H., Yamamoto S., Takahashi T., Horiguchi S., Urasaki Y., Matsuki T., and Fujieda S. Collaborative action of NF-kappaB and p38 MAPK is involved in CpG DNA-induced IFN-alpha and chemokine production in human plasmacytoid dendritic cells. J. Immunol. 177 (2006) 4841-4852
33. Prakash A., Smith E., Lee C.K., and Levy D.E. Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J. Biol. Chem. 280 (2005) 18651-18657
34. Erlandsson L., Blumenthal R., Eloranta M.L., Engel H., Alm G., Weiss S., and Leanderson T. Interferon-beta is required for interferon-alpha production in mouse fibroblasts. Curr. Biol. 8 (1998) 223-226
35. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., and Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
36. Asselin-Paturel C., Brizard G., Chemin K., Boonstra A., O'Garra A., Vicari A., and Trinchieri G. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J. Exp. Med. 201 (2005) 1157-1167
37. Barchet W., Cella M., Odermatt B., Asselin-Paturel C., Colonna M., and Kalinke U. Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J. Exp. Med. 195 (2002) 507-516
38. Waibler Z., Anzaghe M., Ludwig H., Akira S., Weiss S., Sutter G., and Kalinke U. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses. J. Virol. 81 (2007) 12102-12110
39. Dzionek A., Sohma Y., Nagafune J., Cella M., Colonna M., Facchetti F., Gunther G., Johnston I., Lanzavecchia A., Nagasaka T., Okada T., Vermi W., Winkels G., Yamamoto T., Zysk M., Yamaguchi Y., and Schmitz J. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194 (2001) 1823-1834
40. Cao W., Rosen D.B., Ito T., Bover L., Bao M., Watanabe G., Yao Z., Zhang L., Lanier L.L., and Liu Y.J. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J. Exp. Med. 203 (2006) 1399-1405
41. Niewold T.B., Hua J., Lehman T.J., Harley J.B., and Crow M.K. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 8 (2007) 492-502
42. M. Salajegheh, S.K. Kong, J.L. Pinkus, R.J. Walsh, A. Liao, R. Nazareno, A.A. Amato, B. Krastins, C. Morehouse, B.W. Higgs, B. Jallal, Y. Yao, D.A. Sarracino, K.C. Parker, and S.A. Greenberg, Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann. Neurol. 67 (2010) 53-63.